España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Alvaro Torres
Khiron Snatches First Medical Cannabis Contract With One Of Colombia's Largest Insurance Companies
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
Five Latinxs To Watch In The Cannabis Space: Meet The Who's Who At Benzinga's Cannabis Capital Conference In Chicago
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
Five Latinxs To Watch In The Cannabis Space: Meet The Who's Who At Benzinga's Cannabis Capital Conference In Chicago
Khiron Appoints Helen Bellwood (ACA) As Interim CFO
Meet Alvaro Torres, CEO Of Lat Am & UK's Top Medical Marijuana Brand At Benzinga's Cannabis Capital Conference In September
Read More...
Alvaro Torres Recent News
Khiron Reveals Results Of 2022 Annual General And Special Meeting
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, revealed the results of its 2022 annual general and special meeting of shareholders held on June 23, 2022.
Khiron Life Sciences Q1 2022 Financial Results Show Record Revenue In Medical Cannabis
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV: KHRN) (Frankfurt: A2JMZC) released its financial results for the quarter ended March 31, 2022, revealing record revenue in the medical cannabis business.
Cannabis Dispensary Roundup: Where To Buy Rec Marijuana In New Jersey, CBD Spas & More Store Openings
Khiron Opens New Zerenia Clinic And Medical Cannabis Pharmacy In Colombia
How Efficient Is Medicinal Cannabis As Treatment For Chronic Pain? Khiron's Clinical Study Reveals
EXCLUSIVE: Medical Cannabis Innovator Khiron Partners With Health Care Company Teleton In Mexico
Khiron Adds Another Clinic Location In Peru In Partnership With Pain Clinic CDL
Medical marijuana company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) is opening another Zerenia location in Peru in partnership with the renowned pain clinic, CDL. Khiron In Peru Highlights
Cannabis Dispensary Roundup: Cresco Labs, High Tide, Khiron, Cordova Cann
Cresco Labs Opens 14th Florida Medical Cannabis Dispensary
Khiron Life Sciences Q3 Revenue Grows 83% YoY To $2.78M
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced its financial results on Monday for the quarter ended September 30, 2021 reporting revenues of CA$3.52 million ($2.78 million), compared to CA$1.93 million in the same period year ago.
Khiron Life Sciences' Study: 80% Positively Respond To Cannabinoid Treatment For Chronic Pain And Other Conditions
A vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced Wednesday results from its first research study including 1,453 patients from Khiron-owned Zerenia Clinics.
Khiron Life Sciences Reveals 47% QoQ Spike In Medical Revenue, Q2 2021 Cannabis Revenue Increases 68% YoY
Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced its latest financial results Monday, revealing a 68% year-over-year jump in revenue to CA$2.8 million (CA$2.18 million) in the second quarter of 2021. Shares trad
Cannabis Movers & Shakers: Khiron, Aleafia, Green Scientific Labs, 4Front Ventures, Halo Collective, Kiva Sales & Service, Sharp Capital Advisors, Simplifya, Organigram
Khiron Appoints Dr. Eduardo Faveret As Medical Director For Zerenia Brazil
Khiron Cannabis Co To Debut South Of The Border, Obtains High-THC Extract Export Quotas For Mexico
Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) received a quota to export over 700 kg of high-THC extract to Mexico.
How COVID-19 Is Affecting Cannabis Companies in Colombia
As cannabis businesses in North America attempt to navigate the imminent recession, Colombia’s largest cannabis operators are sharing comments of tranquility in the midst of global market turmoil.
The Cannabis Industry's Go-Public Frenzy: A Chat With Companies That IPOed This Year
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week